BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 20462409)

  • 1. A new method to detect loss of heterozygosity using cohort heterozygosity comparisons.
    Green MR; Jardine P; Wood P; Wellwood J; Lea RA; Marlton P; Griffiths LR
    BMC Cancer; 2010 May; 10():195. PubMed ID: 20462409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to Non-Hodgkin's lymphoma.
    Aya-Bonilla C; Green MR; Camilleri E; Benton M; Keane C; Marlton P; Lea R; Gandhi MK; Griffiths LR
    Genes Chromosomes Cancer; 2013 May; 52(5):467-79. PubMed ID: 23341091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL).
    Aya-Bonilla C; Camilleri E; Haupt LM; Lea R; Gandhi MK; Griffiths LR
    BMC Genomics; 2014 May; 15(1):390. PubMed ID: 24885312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic loss during progression of follicular lymphoma.
    Takeuchi S; de Vos S; Takeuchi N; Fermin AC; Grogan TM; Seo H; Said JW; Koeffler HP
    Leuk Res; 2004 Jun; 28(6):567-9. PubMed ID: 15120932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression analysis in aggressive NHL.
    Chan WC; Huang JZ
    Ann Hematol; 2001; 80 Suppl 3():B38-41. PubMed ID: 11757704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis.
    Ross CW; Ouillette PD; Saddler CM; Shedden KA; Malek SN
    Clin Cancer Res; 2007 Aug; 13(16):4777-85. PubMed ID: 17699855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of MZB1 predicts adverse prognosis in chronic lymphocytic leukemia, follicular lymphoma and diffuse large B-cell lymphoma and is associated with a unique gene expression signature.
    Herold T; Mulaw MA; Jurinovic V; Seiler T; Metzeler KH; Dufour A; Schneider S; Kakadia PM; Spiekermann K; Mansmann U; Hiddemann W; Buske C; Dreyling M; Bohlander SK
    Leuk Lymphoma; 2013 Aug; 54(8):1652-7. PubMed ID: 23189934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of genomic imbalances in diffuse large B-cell lymphoma by detailed SNP-chip analysis.
    Scholtysik R; Kreuz M; Hummel M; Rosolowski M; Szczepanowski M; Klapper W; Loeffler M; Trümper L; Siebert R; Küppers R;
    Int J Cancer; 2015 Mar; 136(5):1033-42. PubMed ID: 25042405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays.
    Pfeifer D; Pantic M; Skatulla I; Rawluk J; Kreutz C; Martens UM; Fisch P; Timmer J; Veelken H
    Blood; 2007 Feb; 109(3):1202-10. PubMed ID: 17053054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma.
    Sebastián E; Alcoceba M; Martín-García D; Blanco Ó; Sanchez-Barba M; Balanzategui A; Marín L; Montes-Moreno S; González-Barca E; Pardal E; Jiménez C; García-Álvarez M; Clot G; Carracedo Á; Gutiérrez NC; Sarasquete ME; Chillón C; Corral R; Prieto-Conde MI; Caballero MD; Salaverria I; García-Sanz R; González M
    Ann Hematol; 2016 Jan; 95(2):253-62. PubMed ID: 26573278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and mapping of novel tumor suppressor loci on 6p in diffuse large B-cell non-Hodgkin's lymphoma.
    Nagai H; Kinoshita T; Suzuki H; Hatano S; Murate T; Saito H
    Genes Chromosomes Cancer; 1999 Jul; 25(3):277-83. PubMed ID: 10379874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
    Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
    Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
    Tagawa H
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coincidental LOH regions in mouse and humans: evidence for novel tumor suppressor loci at 9q22-q34 in non-Hodgkin's lymphomas.
    Meléndez B; Cuadros M; Robledo M; Rivas C; Fernández-Piqueras J; Martínez-Delgado B; Benítez J
    Leuk Res; 2003 Jul; 27(7):627-33. PubMed ID: 12681362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma.
    Hu N; Clifford RJ; Yang HH; Wang C; Goldstein AM; Ding T; Taylor PR; Lee MP
    BMC Genomics; 2010 Oct; 11():576. PubMed ID: 20955586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomewide scan for loss of heterozygosity and chromosomal amplification in breast carcinoma using single-nucleotide polymorphism arrays.
    Argos M; Kibriya MG; Jasmine F; Olopade OI; Su T; Hibshoosh H; Ahsan H
    Cancer Genet Cytogenet; 2008 Apr; 182(2):69-74. PubMed ID: 18406867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays.
    Beroukhim R; Lin M; Park Y; Hao K; Zhao X; Garraway LA; Fox EA; Hochberg EP; Mellinghoff IK; Hofer MD; Descazeaud A; Rubin MA; Meyerson M; Wong WH; Sellers WR; Li C
    PLoS Comput Biol; 2006 May; 2(5):e41. PubMed ID: 16699594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Pei J; Robu V; Feder M; Cheung M; Neumann-Domer E; Talarchek J; Dulaimi E; Millenson MM; Testa JR
    Cancer Genet; 2014 Mar; 207(3):98-102. PubMed ID: 24704113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.